GLPwatch
Papers (12034)
Page 177 of 201, ranked by citation count.
- Real-World Use of Semaglutide for Weight Management: Dose Titration, Discontinuation Patterns and Weight Changes.
- Do GLP-1 Receptor Agonists Sabotage Fat Grafts? : A Scoping Review of GLP-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer.
- Current and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review.
- Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes.
- London buses: A cardiovascular outcome trial equivalent?
- Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care.
- Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.
- [SURPASS CVOT : cardiovascular benefits with tirzepatide versus dulaglutide in type 2 diabetes].
- Endoscopic Sleeve Gastroplasty Versus Oral Semaglutide for Obesity: A Real-World Comparative Cohort Study.
- Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide.
- Efficacy and Safety of Semaglutide for Managing Antipsychotic-associated Weight Gain: A Systematic Review and Meta-analysis.
- Semaglutide/Acarbose combination protects against diabetic nephropathy in rats; a novel insight into modulation of Nrf-2/HO-1& TGF-β/Smad pathways.
- GLP-1 Agonists in Orthopedic Surgery: A Narrative Review of Bone Health and Surgical Implications.
- [Towards evidence-based medicine: large-scale intervention trials with glucagon-like peptide-1 receptor agonists].
- A Fluorescent Probe-Based Platform for Precise Pharmaceutical Analysis and Quality Assessment of Tirzepatide.
- Progress and challenges in obesity pharmacotherapy: semaglutide as a milestone.
- Development of a Long-Acting and Stapled Dual Amylin and Calcitonin Receptor Agonist as Monotherapy and Combination with GLP-1R Agonists for the Treatment of Obesity.
- Semaglutide (Wegovy) for weight loss.
- Comparative analysis of IDegLira versus insulin glargine in short-term intensive therapy for overweight or obese patients with type 2 diabetes mellitus.
- The Role of Glucagon-like Peptide 1 Receptor Modulators for the Management of Dumping Syndrome in Patients Who have Undergone Metabolic and Bariatric Surgery: a Scoping Review.
- Glucagon-like peptide-1 receptor (GLP-1R) agonists prevent tributyltin-induced muscle atrophy/wasting via restoring GLP-1R signaling in vitro and in mice.
- Unmasking the risk: euglycemic diabetic ketoacidosis induced by GLP-1 agonist in type 2 diabetes.
- Tirzepatide improves neutrophilic inflammation in obese asthmatic mice by downregulating Th17 cell differentiation.
- Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance.
- Tirzepatide ameliorates cisplatin-induced acute kidney injury by restoring NAMPT/NAD + homeostasis and enhancing Pink1-Parkin-mediated mitophagy.
- Real-World Use of Subsidised Semaglutide in Icelandic Children With Obesity: A Nationwide Retrospective Cohort Study.
- Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.
- [Glucagon-like peptide-1: a cardiological perspective].
- Development and validation of a sensitive HPLC-MS/MS method for the analysis of semaglutide in human plasma.
- Semaglutide Prevents Aortic Rupture and Dissection in the Angiotensin II Mouse Model.
- Incretin-Based Therapies in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Emerging Cardiometabolic Disease Modification Beyond Glycemic Control.
- Severe Perioperative Lactic Acidosis and Hyperglycemia Responsive to Thiamine in a Patient With Prior Semaglutide Use and Restrictive Dieting: A Case Report.
- Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach.
- Hemodynamic and metabolomic responses to infusion of GLP-1 agonist exenatide in pulmonary arterial hypertension.
- Ecnoglutide: First Approvals.
- Real-world data of tirzepatide in obesity management: a multicenter study by the Italian Society of Obesity - Campania Region.
- Calling guidance evidence-based when it is not is against the ethos of science.
- GLP-1 agonist liraglutide decreases operant methamphetamine intake in rats under conditions of short- but not extended-access to the drug.
- THE AUTHORS RESPOND.
- Assessment of lixisenatide-induced nephropathy in chick embryos: Implications for prevention of diabetic kidney disease.
- [Treatment of type 2 diabetes mellitus--which role do GLP-1 receptor agonists play?].
- Targeting Multiple Gut-Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy.
- [<sup>18</sup>F]FB(ePEG12)12-Exendin-4 positron emission tomography/magnetic resonance imaging for precise preoperative localization of a pancreatic-head insulinoma: a case report with review of literature.
- Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-Analysis.
- Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies.
- GLP-1 receptor agonists on WHO-EML 2025 list: major breakthrough bounded by persistent challenge.
- Effects of Semaglutide on BMI and Cardiometabolic Profile in Adolescents With Variants in Monogenic Obesity-Related Genes.
- Tirzepatide affects NAc activity and food preoccupation.
- [Insulin intoxications caused by falsified semaglutide].
- The Novel Tetra-Specific Drug C-192, Conjugated Using UniStac, Alleviates Non-Alcoholic Steatohepatitis in an MCD Diet-Induced Mouse Model.
- Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice.
- Thermosensitive hydrogels for sustained semaglutide release: overcoming weight loss plateau in diet-induced obese rats.
- Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study.
- [Exenatide promotes chemotactic migration of adipose-derived stem cells through SDF-1/CXCR-4/Rho GTPase pathway].
- Diabetes News.
- Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.
- The role of vasopressin deficiency in the fluid intake suppression hyper-responsivity to central glucagon-like peptide-1 in the Brattleboro rat.
- [Degludec/liraglutide] fixed combination as a therapy alternative].
- Unexpected Residual Gastric Contents in a Patient After Holding Semaglutide After Standard Fasting Guidelines: A Case Report.
- Exploring the off-label use of liraglutide in the treatment of obesity: a review.